StreetInsider.com News Articles

Form SCHEDULE 13G/A Galecto, Inc. Filed by: Ikarian Capital, LLC

Fri, 06 Mar 2026 16:43:00 +0000

si-local-file:///var/storage/secattach/20260306/26126184.html

Form SCHEDULE 13G/A Galecto, Inc. Filed by: Ikarian Capital, LLC

Fri, 06 Mar 2026 16:43:00 +0000

si-local-file:///var/storage/secattach/20260306/26126184.html

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 04 Mar 2026 08:00:00 +0000

BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that it granted equity awards on March 2, 2026, to four newly-hired, non-executive employees. The inducement grants were approved by Galecto’s independent Compensation Committee and were made as material inducements to such individuals’ acceptance of employment with Galecto in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement grants consist of non-qualified stock options to purchase an aggregate of 153,700 shares of the Galecto’s common stock with a 10-year term and

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 04 Mar 2026 08:00:00 +0000

The inducement grants consist of non-qualified stock options to purchase an aggregate of 153,700 shares of the Galecto’s common stock with a 10-year term and

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 04 Mar 2026 08:00:00 +0000

The inducement grants consist of non-qualified stock options to purchase an aggregate of 153,700 shares of the Galecto’s common stock with a 10-year term and

Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 04 Mar 2026 08:00:00 +0000

The inducement grants consist of non-qualified stock options to purchase an aggregate of 153,700 shares of the Galecto’s common stock with a 10-year term and

Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference